Eight hybrid cell lines secreting monoclonal antibodies directed against the activated 8-endotoxin of Bacillus thuringiensis var. thuringiensis were grown in BALB/c mice. Ascites fluids were collected, and the antibodies were purified by antigen-affinity chromatography. The specificity of each monoclonal antibody for the toxin and protoxin was established by the indirect enzyme-linked immunosorbent assay. All the antibodies consisted of yl heavy and K light chains. They were reactive with both the native toxin and the protoxin. In contrast to specific goat antiserum, they failed, however, to bind to heat and sodium dodecyl sulfate denatured antigen. These eight cloned cell lines gave rise to five kinds of antibodies distinguished by isoelectric focusing. Competitive antibody binding studies revealed that these five antibodies recognize at least four distinct antigenic determinants of the native toxin and the protoxin. Two of the epitopes are unrelated, whereas three antibodies compete for binding to their antigenic determinants. In the bioassay with larvae of Pieris brassicae, one antibody was found to block the toxin and protoxin activity completely. A second inhibited it partially, whereas the other three antibodies did not affect it at all.
The insecticidal activity of Bacillus thuringiensis is primarily due to the bipyramidal proteinaceous crystal produced by the bacteria as a parasporal inclusion during sporulation. The first symptom of poisoning, cessation offeeding, appears within minutes after the uptake of crystals. The parasporal bodies consist of dimeric subunits with a molecular weight of about 230,000; these subunits are linked together by disulfide bonds (3) . They can be dissolved with retention of toxicity by use of buffer solutions with pH > 8 containing reducing agents.
The parasporal bodies as well as the subunits are protoxins. They are not toxic upon injection into the hemocoel of host larvae or administration to susceptible insect tissue cultures. Enzymatic activation by the gut juice of the larvae is needed in vivo and limited proteolysis with trypsin to yield the activated b-endotoxin is needed in vitro. The protoxin of B. thuringiensis var. thuringiensis, proteolytically activated by trypsin or gutjuice proteases of Pieris brassicae, releases a toxin with a molecular weight of 70,000, which is further degraded to a second one with a mnolecular weight of 55,000. These two toxins differ significantly from the protoxin with respect to amino acid composition (H. Huber-Lukac, Ph.D. thesis, Swiss Federal Institute of Technology, Zurich, 1982) .
Little is known about the active site and the molecular mode of action of the 5-endotoxin. The gut epithelium is believed to be the primary target of the toxin. The specificity of the 8-endotoxin suggests that a component of the gut epithelium is acting as specific receptor.
Specifically designed inactivation studies yielded more information. Heat denaturation of the toxin revealed that the toxin requires its specific conformation to be active (T. Watanabe, R. Tsutsui, H. Iwahana, and K. Abe, Proceedings of the Joint U.S.-Japan Seminar on Microbial Control of Insect Pests, Fukuoka, 1967, p. 71-78). Inactivation achieved by alkylation of the protoxin suggested that sulfhydryl groups are engaged in the toxin action (6) .
Whereas the reduced, native protoxin contains 18 exposed sulfhydryl groups per dimer which can be alkylated, one single cysteine residue remains on the surface after proteolysis. By alkylation of the toxin, however, it was found that this one cysteine is not involved in the biological activity (H. Huber-Lukac, Ph.D. thesis). Inhibition of toxin action was achieved by specific antisera. As these contained heterogenous antibody populations, no particular information could be derived with regard to the number of epitopes, their distribution, or interrelation.
This obstacle could be eliminated by using monoclonal antibodies. We consider monoclonal antibodies a powerful tool for the detailed analysis of the structure-function relationship of the toxin. Therefore, a set of monoclonal antibodies recognizing functionally distinct sites on the b-endotoxin was raised (4) . In this paper we describe the purification and characterization of these ascite-produced antibodies and the antigenic sites of the toxin.
MATERIALS AND METHODS Production of antibodies. Monoclonal antibodies were produced by fusing spleen cells of b-endotoxinimmunized BALB/c mice with SP2/0-Agl4 cells as previously described (4) . Hybridoma cells were grown in ascites form by injecting BALB/c mice intraperitoneally with 1 x 106 to 5 x 106 cells of one of the eight clones. For that purpose, the mice were primed with 0.5 ml of pristane per mouse 1 week before inoculation with hybridoma cells. Ascites fluids were harvested 7 to 14 days after inoculation by tapping the peritoneum with an 18-gauge syringe needle. Cells and debris were removed by centrifugation at 1,000 x g for 30 min. The supernatants were stored at -20°C until use.
Affinity purification of the antibodies. B. thuringiensis var. thuringiensis (serotype H-1, strain LBG B4412) parasporal bodies were purified (2) and dissolved in 0.05 M carbonate buffer, pH 9.5, containing 10 mM dithiothreitol for 30 min at 37°C. An affinity column was prepared by coupling 40 mg of protoxin to 8 ml of Affi-Gel 10 (Bio-Rad Laboratories), as described by the supplier. Ascites fluid in 0.1 M citratephosphate buffer, pH 8.0 (1:1 [vol/vol]) was applied to the column. The column was washed with the same buffer, and the antibodies were eluted with 0.1 M citrate-phosphate buffer, pH 3.0, directly into a neutralizing buffer of 1 M Tris-hydrochloride, pH 9.0. The antibody-containing fractions were combined and dialyzed against 0.01 M phosphate-buffered saline, pH 7.4, concentrated by ultrafiltration, and stored at -20°C until use.
Activation of the protoxin. Dissolved protoxin (5 mg/ml) was digested with 0.5 mg of trypsin per ml of protoxin for 30 min at 37°C. The (5) .
Indirect ELISA. The isolated antibodies were tested by the indirect method for microplate ELISA (7) for binding to the protoxin and toxin. Anti-protoxin goat serum (H. Huber-Lukad, Ph.D. thesis) was used for comparison. Protoxin or toxin (500 ng) in 0.1 ml of coating buffer (7) was incubated overnight in Cooke Microtiter Plates (Dynatech) at 4°C. In the second step, antibodies in different concentrations were incubated and detected as previously described (4) . To test the effect of heat denaturation on protoxin-antibody interaction, protoxin in coating buffer was incubated for 15 min at 25, 37, 56, 65, 75, 85, and 90°C. The effect of SDS denaturation was examined by incubation of protoxin in 0.1% SDS for 2 h at 37°C or for 5 min at 95°C. The treated samples (500 ng) were then coated on ELISA plates; 300 ng of antibodies per well was added, and binding was compared to the binding of 1:50 diluted anti-protoxin goat serum, normal goat serum, and normal mouse serum.
IEF. Isoelectric focusing (IEF) was performed in 2-mm 0.9%o agarose gels, containing 11% sorbitol and 6% Pharmalyte pH 5 to 8 (Pharmacia). Antibody samples (20 ,ug) were applied on paper sample applicators. The high pl kit of Pharmacia was used as standard. IEF was run for 1.5 h at 15 W constant power. The gel was fixed, stained, and destained according to the instructions of the supplier.
CAB. In the competitive antibody binding (CAB) assay, unlabeled and labeled antibodies competed for binding to protoxin. 3H-labeled antibodies were produced as follows. Cells of well growing clones were centrifuged at 200 x g for 15 min and suspended in Dulbecco modified Eagle medium containing [3H]leucine (5 ,uCi/ml). The cells were grown in this medium overnight, and their supernatants containing the 3H-labeled antibodies were collected and stored at -20°C.
The competitive radioimmunoassay was carried out on flexible U-bottomed microtiter plates (Dynatech) coated with 200 ng of protoxin in 50 ,ul of coating buffer (7) overnight at 4°C. Dilutions (1:5) of the culture medium containing the 3H-labeled antibodies were mixed with different concentrations of unlabeled antibody, used as inhibitor, ranging from 0.16 to 32.7 ng/,ul to give a final volume of 50 Ill. The two antibodies were incubated in the protoxin-coated wells overnight at room temperature. The plates were washed and cut, and the single wells were transferred into 5 ml of Aquasol (New England Nuclear) for scintillation counting. Counts from wells without inhibitor were taken as values for 100%o binding. Inhibition was measured as reduction of binding of labeled antibody. Unspecific binding was taken into account by using uncoated wells as negative controls.
Bioassay. The bioassay was performed with larvae of P. brassicae as previously described (4 (Fig. 2D) The interpretation of these findings is that antibodies 38.2, 44.1, and 54.1 are probably not interacting with any site involved in toxin activity. Antibodies 94.1 and 94.2 may interfere with the action of the toxin by binding at or near the active site. Alternatively, they may combine with determinants remote from the active site of the toxin, thereby altering its conformation and, hence, the activity. Which hypothesis is true is not yet clear. However, the following conclusions may be drawn. The binding of the two INFECT. IMMUN. blocking antibodies is related to two nonoverlapping sites, which are independent epitopes on the protoxin since the antibodies did not compete in CAB assays.
If we assume that the toxin has just one active site and that no other site is necessary for its action, this site cannot be accessible in the protoxin as it is inactive. The neutralizing antibodies would have to interact with determinants remote from the active site, inducing their effect by conformational changes.
Alternatively, if two or more sites of the toxin are required for its action, one site could be exposed on the protoxin and the other(s) would not be accessible before proteolytic activation. In this case, the inhibiting antibodies might directly or closely bind to the exposed site. If it could be excluded that the neutralizing antibodies bring about their effect by inducing conformational changes, the mapping of a site involved in toxicity could be initiated. Separation and characterization of determinants related to toxicity could be achieved by examining the antigenic reactivity of proteolytic fragments of the toxin. Future work will have to deal with this problem.
Provided that the antibodies described here do recognize a site required for toxin action, they can be used to determine whether the toxins of different B. thuringiensis varieties vary in their active sites or whether they differ in a possible binding site to a receptor on the gut epithelium. 
